PubMed HealthSearch

PubMed · 384643

Comparative study of cefaclor and amoxicillin in treatment of urinary tract infection.

Abstract

Cefaclor or amoxicillin was given to 51 randomly assigned patients with urinary tract infections. Inclusion in the study required two pretreatment urine cultures yielding the same organism (susceptible to both antibiotics) in concentrations greater than or equal to 10(5)/ml. Both drugs were administered as 250 mg. orally every eight hours for ten days. Cefaclor was given to 27 patients and amoxicillin to 24. Most patients in both groups had negative urine cultures at five to nine days and four to six weeks following therapy. One patient in each group was unsuccessfully treated. Relapse or reinfection occurred with similar frequency in both treatment groups. Both antibiotics were well tolerated. minimal inhibiting concentrations (MICS) of cefaclor, amoxicillin, cephradine, and cephalexin were determined by an agar dilution technique for the 44 available pretreatment isolates (41 Escherichia coli and 3 Proteus mirabilis). Mean MICs (micrograms./ml., +/- SD) were 2.2 +/- 1.4 for cefaclor, 4.4 +/- 2.0 with amoxicillin, 8.1 +/- 4.2 for cephradine, and 5.7 +/- 3.0 with cephalexin. Cefaclor is highly active in vitro against those gram-negative bacteria which are commonly isolated from urine. Cefaclor is as effective as amoxicillin when administered three times daily for the treatment of urinary tract infection.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Rotschafer, K Crossley, D Zaske, R Viste. 1979. Comparative study of cefaclor and amoxicillin in treatment of urinary tract infection.. https://doi.org/10.1016/0090-4295(79)90489-8

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Diarrhoea as a side effect of amoxycillin therapy.

The incidence of loose bowel actions in hospitalized children who were receiving amoxycillin mixture has been studied. A total of 293 patients were observed for the occurrence of loose bowel actions considered not to be due to their disease-state; some 19% of these patients suffered this side effect. The incidence was extremely high in the youngest children, but it diminished as age increased. A control group of patients showed a significantly lower (P less than 0.025) percentage incidence (7.4%) than children who were receiving amoxycillin mixture (18.8%). The dosage per kilogram of body weight per day was found to be unassociated with the incidence of diarrhoea in children below the age of two years; but above that age, children receiving higher doses of amoxycillin mixture were more likely to suffer this side effect than those receiving low doses.

Amoxicillin

Determination of amoxicillin in body fluids by reversed-phase liquid chromatography coupled with a post-column derivatization procedure.

Quantitative methods for determination of amoxicillin in body fluids are described. They comprise separation by reversed-phase chromatography (LiChrosorb RP-8, 5 micron) of the aqueous supernatants obtained from plasma or urine after purification steps involving protein precipitation followed by extraction in the case of plasma, or a double extraction procedure in the case of urine, post-column derivatization with air segmentation, and finally measurement of the UV absorbance at 310 nm. The derivatization involves formation of the mercuric mercaptide of penicillenic acid and is specific for compounds with an intact penicillanic acid ring system. Detection limits achieved on injecting 200 microliter of plasma and 20 microliter of urine are about 25 ng/ml and 200 ng/ml, respectively, but it is possible to improve the sensitivity further by injecting larger volumes. Precisions (srel) obtained for determination of 0.10 and 0.45 migrogram/ml in plasma were 3.72 and 1.40%, respectively. Some problems regarding column stability originating from the injection of biological samples are discussed.

Amoxicillin